New
Service for TodaysSeniorsNetwork.com
readers...roll mouse over, click on
highlighted links in stories to review items
from Amazon
Now, keep up to date
with daily feeds of newly posted stories
about America's Seniors...click on the box
to the left
Experimental
treatment for Type 1 Diabetes patients shows
promise
Newswise — New research
monitoring the effects of Islet cell
transplantation resulted in near-normal
metabolic control and decreased
hypoglycemia.
This research will be
presented at the American Association of
Clinical Endocrinologists (AACE) 17th Annual
Meeting & Clinical Congress, on Friday, May
16th, at the Walt Disney World Dolphin
Resort in Orlando.
During the 18 month
study, physicians used Continuous Glucose
Monitoring Systems to monitor the effects of
the islet cell transplant procedure on
patients with type 1 diabetes. The results
were intriguing.
“Our findings suggest
that the majority of patients with Type 1
diabetes who have received an islet
transplant benefit from near normal
metabolic control, with fewer and shorter
episodes of hypoglycemia,” said Lisa Gorn,
DO, the study’s primary author.
“These patients also
spent longer periods of time in
normoglycemia overall.
At the 2008 AACE Annual
Meeting diabetes will be taking center
stage. A special symposium titled “Clinical
Trials Targeting Glycemia: What Do We Expect
to Learn?” will consider the impact of
glucose control through studies including
ACCORD, ADVANCE, VADT, and others. Related
sessions of interest include “Insulin
Resistance and Atherosclerosis: The Missing
Link,” and “Hypoglycemia: The Limiting
Factor in the Glycemic Management of
Diabetes.”
...
...
...